Nanjing Medlander Medical Technology Co.,Ltd. (SHA:688273)

China flag China · Delayed Price · Currency is CNY
46.95
+1.00 (2.18%)
At close: Jan 23, 2026
110.63%
Market Cap4.59B
Revenue (ttm)437.82M
Net Income (ttm)101.51M
Shares Out97.81M
EPS (ttm)1.04
PE Ratio45.25
Forward PEn/a
Dividend0.60 (1.28%)
Ex-Dividend DateNov 27, 2025
Volume2,133,743
Average Volume5,467,831
Open47.20
Previous Close45.95
Day's Range46.12 - 47.25
52-Week Range21.99 - 61.22
Beta0.02
RSI52.82
Earnings DateApr 16, 2026

About SHA:688273

Nanjing Medlander Medical Technology Co.,Ltd. engages in the research and development, manufacture, sale, and service of pelvic floor rehabilitation equipment and related products in China and internationally. It offers pelvic floor and obstetrics and gynecology rehabilitation, reproductive rehabilitation product, and sports rehabilitation products, as well as consumables products, such as vaginal electrodes, rectal electrodes, vaginal probes, etc. The company also provides pelvic floor muscle rehabilitation, biological feedback and stimulation... [Read more]

Sector Healthcare
Founded 2013
Employees 566
Stock Exchange Shanghai Stock Exchange
Ticker Symbol 688273
Full Company Profile

Financial Performance

In 2024, SHA:688273's revenue was 424.55 million, an increase of 24.57% compared to the previous year's 340.82 million. Earnings were 101.58 million, an increase of 13.10%.

Financial Statements